Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000373755

Medchemexpress LLC DDO-2213 | 2378768-36-4 | C24H27ClFN7O | 100 MG
SDP

Catalog No. 5000373755
Encompass_Preferred

DDO-2213 is an orally active and potent WDR5-MLL1 inhibitor. It selectively inhibits MLL histone methyltransferase activity and the proliferation of MLL translocation-harboring cells.

  • Orally active and potent WDR5-MLL1 inhibitor
  • Selectively inhibits MLL histone methyltransferase activity
  • Inhibits proliferation of MLL translocation-harboring cells
  • Suitable for MLL fusion leukemia research

Catalog No. 50-003-73755 Supplier Medchemexpress LLC Supplier No. HY153331100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

DDO-2213 is an orally active and potent WDR5-MLL1 inhibitor. It selectively inhibits MLL histone methyltransferase activity and the proliferation of MLL translocation-harboring cells.

  • Orally active and potent WDR5-MLL1 inhibitor
  • Selectively inhibits MLL histone methyltransferase activity
  • Inhibits proliferation of MLL translocation-harboring cells
  • Suitable for MLL fusion leukemia research

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.